Trial no.:
|
PACTR202312623511104 |
Date of Approval:
|
04/12/2023 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
M-TAPA block versus subcostal TAP block for analgesia after laparoscopic cholecystectomy, a non-inferiority randomized trial |
Official scientific title |
Modified thoracoabdominal nerve block through perichondral approach versus subcostal transversus abdominus plane block for analgesia after laparoscopic cholecystectomy, a non-inferiority randomized trial |
Brief summary describing the background
and objectives of the trial
|
Laparoscopic cholecystectomy (LC) is the mainstay treatment of benign biliary disease. Laparoscopy is a minimally invasive procedure, but postoperative pain is still the most common symptom after LC. In this study, the postoperative analgesic effect of ultrasound-guided modified thoracoabdominal nerves blocks through perichondrial approach (M-TAPA) and oblique subcostal transversus abdominis plane block (OSTAP) will be investigated in patients recruited for LC. It is hypothesized that M-TAPA will reduce opioid consumption of the patients more than the OSTAP block.1,2
Oblique subcostal transversus abdominis plane (OSTAP) block is a regional anesthesia technique defined for abdominal surgeries. Previously, several studies have reported that ultrasound-guided OSTAP blocks reduce pain scores after LC. Performing OSTAP can be challenging in obese patients or in patients with transverse abdominal incisions for previous surgeries. 3 4,5
M-TAPA block is performed by applying local anesthetic to the lower surface of the chondrium resulting in effective analgesia in the abdominal wall resulting in wider dermatomal analgesia through blocking the anterior and lateral branches of thoracoabdominal nerves T5-L.6
This study aims to compare the efficacy of M-TAPA block as an alternative to OSTAP for analgesia after laparoscopic cholecystectomy. The hypothesis of this study is that M-TAPA is an equivalent alternative to OSTAP producing comparable analgesic profile. The primary objective will the mean postoperative numeric rating scale (NRS) score in the 1st postoperative day, while secondary objectives will include the hourly postoperative NRS score after surgery at rest and at movement, postoperative morphine consumption, the incidence of postoperative nausea and vomiting (PONV).
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Anaesthesia,Surgery |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Prevention |
Anticipated trial start date |
20/12/2023 |
Actual trial start date |
05/12/2023 |
Anticipated date of last follow up |
20/02/2024 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
64 |
Actual target sample size (number of participants) |
|
Recruitment status |
Recruiting |
Publication URL |
|
|